Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
TTGT TechTarget Inc
GBBFF Granada Gold Mine Inc
SPTM SPDR® Portfolio Total Stock Market ETF
LMTI Laser Master International Inc
IPIX Innovation Pharmaceuticals Inc
PFF iShares Preferred and Income Securities ETF
BAC Bank of America Corp
INB Cohen & Steers Global Income Builder Inc
MSSZF Massimo Zanetti Beverage Group SpA
Go

Health Care : Pharmaceuticals |
Based in CanadaCompany profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Closing Price
$39.01
Day's Change
-1.69 (-4.15%)
Bid
--
Ask
--
B/A Size
--
Day's High
40.48
Day's Low
38.70
Volume
(Light)
Volume:
1,370,357

10-day average volume:
2,126,313
1,370,357

Company Profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
67.81x
Price/Book (MRQ)
10.32x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

May 2019
Current Month
6.4M
Previous Month
5.3M
Percent of Float
29.24%
Days to Cover
5.4281 Days

Share Information

TLRY is in a share class of common stock
Float
5.3M
Shares Outstanding
97.2M
Institutions Holding Shares
140
3.34%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in millions.

Company Officers

  • Brendan KennedyPres.
  • Mark CastanedaCFO
  • Kristina AdamskiExec.VP
  • Edward Wood PastoriusOther
  • Andrew PucherOther

Address

Insider Trading

During the most recent quarter, 523K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by , Copyright © 2019. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.